297 related articles for article (PubMed ID: 17038709)
1. BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin.
Nackers F; Dramaix M; Johnson RC; Zinsou C; Robert A; DE Biurrun Bakedano E; Glynn JR; Portaels F; Tonglet R
Am J Trop Med Hyg; 2006 Oct; 75(4):768-74. PubMed ID: 17038709
[TBL] [Abstract][Full Text] [Related]
2. Environmental and health-related risk factors for Mycobacterium ulcerans disease (Buruli ulcer) in Benin.
Nackers F; Johnson RC; Glynn JR; Zinsou C; Tonglet R; Portaels F
Am J Trop Med Hyg; 2007 Nov; 77(5):834-6. PubMed ID: 17984337
[TBL] [Abstract][Full Text] [Related]
3. Association between haemoglobin variants S and C and Mycobacterium ulcerans disease (Buruli ulcer): a case-control study in Benin.
Nackers F; Tonglet R; Slachmuylder V; Johnson RC; Robert A; Zinsou C; Glynn JR; Portaels F; Gala JL
Trop Med Int Health; 2007 Apr; 12(4):511-8. PubMed ID: 17445142
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for Buruli ulcer, Benin.
Debacker M; Portaels F; Aguiar J; Steunou C; Zinsou C; Meyers W; Dramaix M
Emerg Infect Dis; 2006 Sep; 12(9):1325-31. PubMed ID: 17073079
[TBL] [Abstract][Full Text] [Related]
5. Buruli ulcer disease in Cameroon rediscovered.
Noeske J; Kuaban C; Rondini S; Sorlin P; Ciaffi L; Mbuagbaw J; Portaels F; Pluschke G
Am J Trop Med Hyg; 2004 May; 70(5):520-6. PubMed ID: 15155984
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease.
Portaels F; Aguiar J; Debacker M; Guédénon A; Steunou C; Zinsou C; Meyers WM
Infect Immun; 2004 Jan; 72(1):62-5. PubMed ID: 14688081
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana.
Raghunathan PL; Whitney EA; Asamoa K; Stienstra Y; Taylor TH; Amofah GK; Ofori-Adjei D; Dobos K; Guarner J; Martin S; Pathak S; Klutse E; Etuaful S; van der Graaf WT; van der Werf TS; King CH; Tappero JW; Ashford DA
Clin Infect Dis; 2005 May; 40(10):1445-53. PubMed ID: 15844067
[TBL] [Abstract][Full Text] [Related]
8. Prospects for vaccine development against Buruli disease.
Huygen K
Expert Rev Vaccines; 2003 Aug; 2(4):561-9. PubMed ID: 14711340
[TBL] [Abstract][Full Text] [Related]
9. Systemic suppression of interferon-gamma responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans.
Yeboah-Manu D; Peduzzi E; Mensah-Quainoo E; Asante-Poku A; Ofori-Adjei D; Pluschke G; Daubenberger CA
J Leukoc Biol; 2006 Jun; 79(6):1150-6. PubMed ID: 16531561
[TBL] [Abstract][Full Text] [Related]
10. Assessing water-related risk factors for Buruli ulcer: a case-control study in Ghana.
Aiga H; Amano T; Cairncross S; Adomako J; Nanas OK; Coleman S
Am J Trop Med Hyg; 2004 Oct; 71(4):387-92. PubMed ID: 15516631
[TBL] [Abstract][Full Text] [Related]
11. Buruli ulcer: the third most common mycobacterial infection.
Weir E
CMAJ; 2002 Jun; 166(13):1691. PubMed ID: 12126327
[No Abstract] [Full Text] [Related]
12. [Epidemiologicl aspects of Buruli ulcer in Côte d'Ivoire: results of a national survey].
Kanga JM; Kacou ED
Bull Soc Pathol Exot; 2001 Mar; 94(1):46-51. PubMed ID: 11346983
[TBL] [Abstract][Full Text] [Related]
13. [Buruli ulcer (Mycobacterium ulcerans infection); report from the International Congress in Yamoussoukro, Ivory Coast].
van der Graaf WT; Scherpbier RW; van der Werf TS
Ned Tijdschr Geneeskd; 1999 Feb; 143(6):312-6. PubMed ID: 10221089
[TBL] [Abstract][Full Text] [Related]
14. Buruli ulcer (Mycobacterium ulcerans infection).
Walsh DS; Portaels F; Meyers WM
Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):969-78. PubMed ID: 18657836
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer).
Portaels F; Aguiar J; Debacker M; Steunou C; Zinsou C; Guédénon A; Meyers WM
Clin Diagn Lab Immunol; 2002 Nov; 9(6):1389-91. PubMed ID: 12414782
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity.
Debacker M; Aguiar J; Steunou C; Zinsou C; Meyers WM; Scott JT; Dramaix M; Portaels F
Trop Med Int Health; 2004 Dec; 9(12):1297-304. PubMed ID: 15598261
[TBL] [Abstract][Full Text] [Related]
17. [The contribution of skin autograft in open air in the treatment of the Buruli ulcer].
Kibadi Kapay A; Mputu-Yamba JB; Muyembe T; Bonga G; N'Siala A
Bull Soc Pathol Exot; 2005 Apr; 98(1):21-5. PubMed ID: 15915968
[TBL] [Abstract][Full Text] [Related]
18. [Distribution of Mycobacterium ulcerans (Buruli ulcer) in the district of Lalo in Benin].
Johnson RC; Sopoh GE; Boko M; Zinsou C; Gbovi J; Makoutode M; Portaels F
Trop Med Int Health; 2005 Sep; 10(9):863-71. PubMed ID: 16135193
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of bacillus Calmette Guerin (BCG) vaccination against extra-pulmonary tuberculosis: a case-control study.
Zodpey SP; Maldhure BR; Dehankar AG; Shrikhande SN
J Commun Dis; 1996 Jun; 28(2):77-84. PubMed ID: 8810141
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of childhood pulmonary tuberculosis: a case control study in Nagpur, India.
Zodpey SP; Shrikhande SN; Maldhure BR; Vasudeo ND; Kulkarni SW
Southeast Asian J Trop Med Public Health; 1998 Jun; 29(2):285-8. PubMed ID: 9886114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
